Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Hsp90 regulation of fibroblast activation in pulmonary fibrosis.

Sontake V, Wang Y, Kasam RK, Sinner D, Reddy GB, Naren AP, McCormack FX, White ES, Jegga AG, Madala SK.

JCI Insight. 2017 Feb 23;2(4):e91454. doi: 10.1172/jci.insight.91454.

2.

Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis.

Chanda D, Kurundkar A, Rangarajan S, Locy M, Bernard K, Sharma NS, Logsdon NJ, Liu H, Crossman DK, Horowitz JC, De Langhe S, Thannickal VJ.

Sci Rep. 2016 Nov 21;6:37445. doi: 10.1038/srep37445.

3.

Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.

Madala SK, Sontake V, Edukulla R, Davidson CR, Schmidt S, Hardie WD.

Am J Respir Cell Mol Biol. 2016 Dec;55(6):792-803.

PMID:
27438654
4.

Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.

Sontake V, Shanmukhappa SK, DiPasquale BA, Reddy GB, Medvedovic M, Hardie WD, White ES, Madala SK.

J Immunol. 2015 Oct 15;195(8):3978-91. doi: 10.4049/jimmunol.1500963. Epub 2015 Sep 14.

5.

Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer.

Liang SQ, Marti TM, Dorn P, Froment L, Hall SR, Berezowska S, Kocher G, Schmid RA, Peng RW.

Cell Death Dis. 2015 Jul 16;6:e1824. doi: 10.1038/cddis.2015.195.

6.

A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.

Lin C, Yao E, Chuang PT.

Dev Biol. 2015 Jul 1;403(1):101-13. doi: 10.1016/j.ydbio.2015.04.014. Epub 2015 Apr 24.

7.

Regulatory mechanisms of betacellulin in CXCL8 production from lung cancer cells.

Shi L, Wang L, Wang B, Cretoiu SM, Wang Q, Wang X, Chen C.

J Transl Med. 2014 Mar 16;12:70. doi: 10.1186/1479-5876-12-70.

8.

Dual targeting of MEK and PI3K pathways attenuates established and progressive pulmonary fibrosis.

Madala SK, Edukulla R, Phatak M, Schmidt S, Davidson C, Acciani TH, Korfhagen TR, Medvedovic M, Lecras TD, Wagner K, Hardie WD.

PLoS One. 2014 Jan 27;9(1):e86536. doi: 10.1371/journal.pone.0086536. eCollection 2014.

9.

Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.

Varma S, Mahavadi P, Sasikumar S, Cushing L, Hyland T, Rosser AE, Riccardi D, Lu J, Kalin TV, Kalinichenko VV, Guenther A, Ramirez MI, Pardo A, Selman M, Warburton D.

Am J Physiol Lung Cell Mol Physiol. 2014 Mar 1;306(5):L405-19. doi: 10.1152/ajplung.00143.2013. Epub 2013 Dec 27.

10.

Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition.

Vyas-Read S, Wang W, Kato S, Colvocoresses-Dodds J, Fifadara NH, Gauthier TW, Helms MN, Carlton DP, Brown LA.

Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15;306(4):L326-40. doi: 10.1152/ajplung.00074.2013. Epub 2013 Dec 27.

11.

Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-α-induced pulmonary fibrosis.

Madala SK, Edukulla R, Schmidt S, Davidson C, Ikegami M, Hardie WD.

Am J Respir Cell Mol Biol. 2014 Apr;50(4):777-86. doi: 10.1165/rcmb.2013-0042OC.

13.

Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition.

Balli D, Ustiyan V, Zhang Y, Wang IC, Masino AJ, Ren X, Whitsett JA, Kalinichenko VV, Kalin TV.

EMBO J. 2013 Jan 23;32(2):231-44. doi: 10.1038/emboj.2012.336. Epub 2013 Jan 4.

14.

Resistin-like molecule α1 (Fizz1) recruits lung dendritic cells without causing pulmonary fibrosis.

Madala SK, Edukulla R, Davis KR, Schmidt S, Davidson C, Kitzmiller JA, Hardie WD, Korfhagen TR.

Respir Res. 2012 Jun 22;13:51. doi: 10.1186/1465-9921-13-51.

15.

Altered DNA methylation profile in idiopathic pulmonary fibrosis.

Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Thannickal VJ, Hagood JS.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):525-35. doi: 10.1164/rccm.201201-0077OC. Epub 2012 Jun 14.

16.

Genetically manipulated mouse models of lung disease: potential and pitfalls.

Baron RM, Choi AJ, Owen CA, Choi AM.

Am J Physiol Lung Cell Mol Physiol. 2012 Mar 15;302(6):L485-97. doi: 10.1152/ajplung.00085.2011. Epub 2011 Dec 23. Review.

17.

MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation.

Madala SK, Schmidt S, Davidson C, Ikegami M, Wert S, Hardie WD.

Am J Respir Cell Mol Biol. 2012 Mar;46(3):380-8. doi: 10.1165/rcmb.2011-0237OC. Epub 2011 Oct 20.

18.

Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Atochina-Vasserman EN, Bates SR, Zhang P, Abramova H, Zhang Z, Gonzales L, Tao JQ, Gochuico BR, Gahl W, Guo CJ, Gow AJ, Beers MF, Guttentag S.

Am J Respir Crit Care Med. 2011 Aug 15;184(4):449-58. doi: 10.1164/rccm.201011-1882OC.

Supplemental Content

Support Center